SERUM LEVEL AND URINARY-EXCRETION OF THIAMAZOL-C-14 IN PATIENTS WITH HYPERTHYROIDISM

被引：7

作者：

BALZER, J

LAHRTZ, H

VANZWIETEN, PA

机构：

[1] UNIV KIEL,MED KLIN 2 & POLIKLIN,METZ STR 53-57,23 KIEL,FED REP GER

[2] UNIV AMSTERDAM,LAB BIOFARM,ROETERS STR 1,AMSTERDAM,NETHERLANDS

来源：

关键词：

D O I：

10.1055/s-0028-1106254

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：548 / 552

页数：5

共 7 条

[1] METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN
ALEXANDER, WD
EVANS, V
MACAULAY, A
GALLAGHER, TF
LONDONO, J
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652): : 290 - +
[2] EFFECT OF HYPERTHYROIDISM ON RENAL CONCENTRATING MECHANISM IN HUMANS
CUTLER, RE
GLATTE, H
DOWLING, JT
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (04) : 453 - +
[3] DOST-ASTI, 2020, PHILS
[4] LAHRTZ H, 1969, Pharmacologia Clinica, V1, P114, DOI 10.1007/BF00404656
[5] CONCENTRATION OF S-35-PROPYLTHIOURACIL BY THYROID GLAND AND ITS RELATIONSHIP TO ANION TRAPPING MECHANISM
MARCHANT, B
ALEXANDER, WD
ROBERTSON, JW
LAZARUS, JH
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1971, 20 (11): : 989 - +
[6] RELATION BETWEEN LIPID SOLUBILITY OF PHARMACEUTICS AND THEIR PHARMACOKINETIC BEHAVIOR
RAAFLAUB, J
[J]. EXPERIENTIA, 1970, 26 (05): : 457 - &
[7] SITAR DS, 1972, J PHARMACOL EXP THER, V183, P440